CC Small or few human trials. Promising, not proven. How we grade →Randomized controlled trial · 84 Chinese men with high cholesterol in Hong Kong
Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial
JV Zhao, WF Yeung, YH Chan, et al. Nutrients. 2021.
- In plain language
- Berberine 500 mg twice a day for 12 weeks lowered total cholesterol 0.39 mmol/L more than placebo and HDL slightly; triglycerides, blood pressure and weight did not change.
- Limits
- Small, men only, 12 weeks; publicly funded (Hong Kong Health and Medical Research Fund), no conflicts declared.
- Which of our grades it feeds
- CC Small or few human trials. Promising, not proven. How we grade →Science summary: Berberine and glucose metabolism
- Source
- doi.org/10.3390/nu13082550 · PubMed 34444711 · Free full text
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. We sell some of what we grade.